Dr Anat Achiron of the Israel’s Sheba Medical Center in Tel-Hashomer has reported that in controlled trials, a synthetic analog of vitamin D significantly reduced fatigue, which is common in patients with multiple sclerosis. The compound is 1a-hydroxyvitamin D3 (alfacalcidol).
http://eng.sheba.co.il/Sheba_News/412.htm